TNNI3K plays a critical role in modulating disease progression in murine models of cardiomyopathy and heart failure, identifying it as a potential novel target for therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
Positions TNNI3K as potential heart failure target; leaves open translation from murine models to patients.
Wheeler et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: